FATTY ACIDS - CARCINOGENESIS MODIFYING FACTORS
DOI:
https://doi.org/10.56782/pps.51Keywords:
polyunsaturated fatty acids, cancer, eicosanoids, dietAbstract
There is both epidemiological and experimental evidence, that dietary polyunsaturated fatty acids (PUFA), modify the risk of breast, colon and prostate cancer incidence. This is related to the n-6:n-3 PUFA ratio which should be as 4-5:1. Higher n-6:n-3 PUFA ratio is thought to promote carcinogenesis. PUFAs n-3 appear to protect from tumour incidence.
Downloads
References
G. M. Williams: Food: its role in the etiology of cancer. K. W. Waldron, I. T. Johnson, G. R. Fenwick: Food and cancer prevention: chemical and biological aspects. The Royal Society of Chemistry 1993, 3 - 11.
R. Doll, R. Peto: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United State today. Journal of National Cancer Institute 66, 1191 - 1308, 1981. DOI: https://doi.org/10.1093/jnci/66.6.1192
H. Bartsch, J. Nair, R. W. Owen: Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 20, 2209 - 2218, 1999. DOI: https://doi.org/10.1093/carcin/20.12.2209
D. P. Rose: Dietary fatty acids and cancer. American Journal of Clinical Nutrition 66, 998S - 1003S, 1997. DOI: https://doi.org/10.1093/ajcn/66.4.998S
E. L. Wynder, B.S. Reddy, J. H. Weisburger: Environmental dietary factors in colorectal cancer: some unresolved tissues. Cancer 70 (suppl. 5), 1222 - 1228, 1992. DOI: https://doi.org/10.1002/1097-0142(19920901)70:3+<1222::AID-CNCR2820701506>3.0.CO;2-N
R. A. Woutersen, M. J. Appel, A. Ven Garderen-Hoetmer, M. V. W. Wijnands: Dietary fat and carcinogenesis. Mutation Research 443, 111 - 127, 1999. DOI: https://doi.org/10.1016/S1383-5742(99)00014-9
Y. E. M. Dommels, G. M. Alink, P. J. van Bladern, B. van Ommen: Dietary n-6 and n-3 fatty acids and colorectal carcinogenesis: results from cultured colon cells, animal models and human studies. Environmental Toxicology and Pharmacology 12, 233 - 244, 2002. DOI: https://doi.org/10.1016/S1382-6689(02)00095-9
R. Holman: -3 and -6 essential fatty acid status in human health and disease. Handbook of Essential Fatty Acid Biology: Biochemistry, Physiology, and Behavioral Neurology (red. S. Yehuda, D. I. Mostofsky) Humane Press Inc., Totowa, New Jersey, 1997, 139 - 182. DOI: https://doi.org/10.1007/978-1-4757-2582-7_7
W. E. M. Lands, A. Morris, B. Libelt: Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids 25, 505 - 615, 1990. DOI: https://doi.org/10.1007/BF02537156
S. B. Eaton, M. Konner: Paleolithic nutrition. A consideration of its nature and current implications. New England Journal of Medicine 312, 283 - 289, 1985. DOI: https://doi.org/10.1056/NEJM198501313120505
A. P. Simopoulos: Essential fatty acids in health and chronic disease. American Journal of Clinical Nutrition 70, 560S - 569S, 1999. DOI: https://doi.org/10.1093/ajcn/70.3.560s
M. J. James, R. A. Gibson, L. G. Cleland: Dietary polyunsaturated fatty acids and inflammatory mediator production. American Journal of Clinical Nutrition 71 (suppl.), 343S - 348S, 2000. DOI: https://doi.org/10.1093/ajcn/71.1.343s
E. Mantzioris, L. G. Cleland, R. A. Gibson, M. A. Neumann, M. Demasi, M. J. James: Biochemical effects of a diet containing foods enriched with n-3 fatty acids. American Journal of Clinical Nutrition 72, 42 - 48, 2000. DOI: https://doi.org/10.1093/ajcn/72.1.42
J. Dyerberg, H. O. Bang, E. Stofferson, S. Moncada, J. R. Vane: Eicosapentaenoic acid and prevention of thrombosis and artheriosclerosis. Lancet 2 (8081), 117 - 119, 1978. DOI: https://doi.org/10.1016/S0140-6736(78)91505-2
S. D. Hursting, M. Thornquist, M. M. Henderson: Types of dietary fat and the incidence of cancer at five sites. Preventive Medicine 19, 242 - 263, 1990. DOI: https://doi.org/10.1016/0091-7435(90)90025-F
C. P. J. Caygill, A. Charlett, M. J. Hill: Fat, fish, fish oil and cancer. British Journal of Cancer 74, 159 - 164, 1996. DOI: https://doi.org/10.1038/bjc.1996.332
C. W. Welsch: Review of the effect of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation. Free Radical Biology and Medicine 18, 757 - 773, 1995. DOI: https://doi.org/10.1016/0891-5849(94)00187-O
R. G. Ziegler, R. N. Hoover, M. C. Pike i wsp.: Migration patterns and breast cancer risk in Asian-American women. Journal of the National Cancer Institute 85, 1819 - 1827, 1993. DOI: https://doi.org/10.1093/jnci/85.22.1819
W. J. Blot, A. Lanier, J. F. Fraumen, T. R. Bender: Cancer mortality among Alaskan natives, 1960 - 69. Journal of the National Cancer Institute 55, 547 - 554, 1975. DOI: https://doi.org/10.1093/jnci/55.3.547
H. O. Bang, J. Dyerberg, N. Hjorne: The composition of food consumed by Greenland Eskimos. Acta Med. Scand. 200, 69 - 73, 1976. DOI: https://doi.org/10.1111/j.0954-6820.1976.tb08198.x
N. Simonsen, P. van’t Veer, J. J. Strain i wsp.: Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the EURAMIC study. American Journal of Epidemiology 147, 342 - 352, 1998. DOI: https://doi.org/10.1093/oxfordjournals.aje.a009456
G. Assmann, G. De Backer, S. Bagnara, J. Betteridge, G. Crepaldi, A. Fernandez-Cruz, J. Godtfredsen, B. Jacoto, R. Paoletti, S. Renaud, G. Ricci, E. Rocha, E. Trautwein, G. C. Urbinati, G. Varely, C. Williams: International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. European Journal of Cancer Prevention 6, 418 - 421, 1997. DOI: https://doi.org/10.12968/bjon.1997.6.12.675
C. W. Welsch, J. L. House, B. L. Herr, S. J. Eliasberg, M. A. Welsch: Enhancement of mammary carcinogenesis by high levels of dietary fat: a phenomenon dependent on ad libitum feeding. Journal of the National Cancer Institute 82, 1615 - 1620, 1990. DOI: https://doi.org/10.1093/jnci/82.20.1615
L. M. Braden, K. K. Carroll: Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids 21, 285 - 288, 1986. DOI: https://doi.org/10.1007/BF02536414
D.-Y. Kim, K.-H. Chung, J-H. Lee: Stimulatory effects of high-fat diets on colon cell proliferation depend on the type of dietary fat and site of the colon. Nutrition and Cancer 30, 118 - 123, 1998. DOI: https://doi.org/10.1080/01635589809514650
V. L. Imrhan, A. M. Hsueh: Effects of type and level of dietary fat during the preinitiation phase of mammary carcinogenesis in rats. Nutrition Research 18, 543 - 555, 1998. DOI: https://doi.org/10.1016/S0271-5317(98)00041-4
G. J. Hopkins, T. G. Kennedy, K. K. Carroll: Polyunsatirated fatty acids as promoters of mammary carcinogenesis induced in Sprague-Dawley rats by 7, 12- dimethylbenzanthracene. Journal of the National Cancer Institute 66m 517 - 522, 1981.
K. K. Carroll, G. J. Hopkins: Dietary Polyunsaturated fat versus saturated fat in relation to mammary carcinogenesis. Lipids 14, 155 - 158, 1979. DOI: https://doi.org/10.1007/BF02533866
C. Ip, C. A. Carter, M. M. Ip: Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Research 45, 1997 - 2001, 1985.
R. A. Karmali, J. Marsh, Ch. Fuchs: Effect of omega-3 fatty acids on growth of a rat mammary tumor. Journal of the National Cancer Institute 73, 457 - 461, 1984. DOI: https://doi.org/10.1093/jnci/73.2.457
S. H. Abou-El-Ela, K. W. Prasse, R. Carroll, A. E. Wade, S. Dharwadkar, O. R. Bunce: Eicosanoid synthesis in 7, 12- dimethylbenz(a)anthracene-induced mammary carcinomas in Sprague-Dawley rats fed primrose oil, menhaden oil or corn oil diet. Lipids 23, 948 - 954, 1988. DOI: https://doi.org/10.1007/BF02536342
J. J. Jurkowski, W. T. Cave: Dietary effects of menhaden oil on the growth and membrane lipid composition on rat mammary tumors. Journal of the National Cancer Institute 74, 1145 - 1150, 1985.
E. A. Hudson, S. A. Beck, M. J. Tisdale: Kinetics of the inhibition of tumor growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochemical Pharmacology 45, 2189 - 2194, 2003. DOI: https://doi.org/10.1016/0006-2952(93)90188-3
J. M. Connolly, E. M. Gilhooly, D. P. Rose: Effect of reduced dietary linoleic acid intake, alone or combined with algal sources of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutrition and Cancer 35, 44 - 49, 1999. DOI: https://doi.org/10.1207/S1532791444-49
R. A. Karmali, H. T. Thaler, L. A. Cohen: Prostaglandin concentrations and prostaglandin synthetase activity in N-nitrosomethylurea-induced mammary adenocarcinoma. European Journal of Cancer Clinical Oncology 19, 817 - 823, 1983. DOI: https://doi.org/10.1016/0277-5379(83)90014-7
S. H. Abou-El-Ela, K. W. Prasse, R. L. Farrell, R. W. Carroll, A. E. Wade, O. R. Bunce: Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Research 49, 1434 - 1440, 1989.
M. R. I. Young: Eicosanoids and the immunology of cancer. Cancer and Metastasis Reviews 13, 337 - 348, 1994. DOI: https://doi.org/10.1007/BF00666103
T. H. Stewart, A. C. Hollinshead, S. Raman: Tumour dormancy; initiation, maintenance and termination in animals and humans. Cancer Journal of Surgery 34, 321 - 325, 1991.
A. Beunett, M. Del Tacca, I. F. Stamfoord, T. Zebro: Prostaglandins from tumots of human large bowel. British Journal of Cancer 35, 881 - 884, 1977. DOI: https://doi.org/10.1038/bjc.1977.132
T. Narisawa, H. Kusaka, Y Yamazaki, M. Takahashi, H. Koyama i wsp.: Relationship between blood plasma prostaglandin E2 and liver link metastases in colorectal cancer. Diseases of Colon and Rectum 33, 840 - 845, 1990. DOI: https://doi.org/10.1007/BF02051919
I. Klapan, V. Katic, F. Culo, D. Sabolovic, V. Cuk, K. Fumic, S. Simovic: Lipid-bound sialic acid, prostaglandin E and histamine in head and neck cancer. European Journal of Cancer 29A, 839 - 845, 1993. DOI: https://doi.org/10.1016/S0959-8049(05)80420-4
Ch. A. Gogos, A. Skoutelis, F. Kalfarentzos: The effect of lipids on the immune response of patients with cancer. The Journal of Nutrition, Health and Ageing 4, 172 - 175, 2000.
J. L. Jenski, L. K. Sturdevant, W. D. Ehringer, W. Stillwell: Omega-3 fatty acid modifications of membrane structure and function: I. Dietary manipulation of tumor cell susceptibility to cell and complement-mediated lysis. Nutrition and Cancer 19, 135 - 146, 1993. DOI: https://doi.org/10.1080/01635589309514244
W. Pascale, W. D. Ehringer, W. Stillwell, L. K. Sturdevant, L. J. Jenski: Omega-3 fatty acid modification of membrane structure and function: II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis. Nutrition and Cancer 19, 147 - 157, 1993. DOI: https://doi.org/10.1080/01635589309514245
W. Stillwell, W. Ehringer, L. J. Jenski: Docosahexaenoic acid increases permeability of lipid bilayers and tumour cells. Lipids 28, 103 - 108, 1993. DOI: https://doi.org/10.1007/BF02535772
C. P. Burns, A. A. Spector: Effects of lipids on cancer therapy. Nutrition Reviews 48, 233 - 240, 1990. DOI: https://doi.org/10.1111/j.1753-4887.1990.tb02946.x
G. Calviello, P. Palozza, E. Piccioni, N. Maggiano, A. Frattucci, P. Franceschelli, G. M. Bartoli: Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects of proliferation and apoptosis. International Journal of Cancer 75, 699 - 705, 1998. DOI: https://doi.org/10.1002/(SICI)1097-0215(19980302)75:5<699::AID-IJC7>3.0.CO;2-U
L. Masotti, E. Casali, T. Galeotti: Lipid peroxidation in tumor cells. Free Radical Biology and Medicine 4, 377 - 386, 1988. DOI: https://doi.org/10.1016/0891-5849(88)90089-5
R. Kumaraguruparan, R. Sybapriya, P. Viswanathan, S. Nagini: Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clinica Chimica Acta 325, 165 - 170, 2002. DOI: https://doi.org/10.1016/S0009-8981(02)00292-9
M. E. Bégin, G. Ells, U. N. Das, D. F. Horrobin: Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. Journal of the National Cancer Institute 77, 1053 - 1062, 1986.
A. Colquhoun, R. I. Schumacher: -Linolenic acid and eicosapentaenoic acid induce modifications in mitochondrial metabolism, reactive oxygen species generation, lipid peroxidation and apoptosis in Walker 256 rat carcinoma cells. Biochimica et Biophysica Acta 1533, 207 - 219, 2001. DOI: https://doi.org/10.1016/S1388-1981(01)00136-6
M. E. Bégin, S. Sircar, J. M. Weber: Differential sensitivity of tumorigenic and genetically related non-tumorigenic cells to cytotoxic polyunsaturated fatty acids. Anticancer Research 9, 1049 - 1052, 1989.
M. E. Bégin, G. Ells, D. Horrobin: Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. Journal of the National Cancer Institute 80, 188 - 194, 1988. DOI: https://doi.org/10.1093/jnci/80.3.188
S. Vartak, R. McCaw, C. S. Davis, M. E. C. Robbins, A. A. Spector: -Linolenic acid (GLA) is cytotoxic to 36B10malignant rat astrocytoma cells but not to “normal" rat astrocytes. British Journal of Cancer 77, 1612 - 1620, 1998. DOI: https://doi.org/10.1038/bjc.1998.264
P. Palozza, G. Calviello, N. Maggiano, P. Lanza, F. O. Ranelletti, G. M. Bartoli: Beta-carotene antagonizes the effects of eicosapentaenoic acid on cell growth and lipid peroxidation in WiDr adenocarcinoma cells. Free Radical Biology and Medicine 28, 228 - 234, 2000. DOI: https://doi.org/10.1016/S0891-5849(99)00225-7
H. A. Leaver, S. B. Wharton, H. S. Bell, I. M. M. Leaver-Yap, I. R. Whittle: Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: effect on tumour biomass, apoptosis and neuronal tissue histology. Prostaglandins, Leukotrienes and Essential Fatty Acids 67, 283 - 292, 2002. DOI: https://doi.org/10.1054/plef.2002.0431
M. J. Gonzalez, R. A. Schemme, L. Dugan, J. I. Gray, C. W. Welsch: Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids 28, 827 - 832, 1993. DOI: https://doi.org/10.1007/BF02536237
C. Lhuillery, S. Cognault, E. Germain, M. L. Jourdan, P. Bougnoux: Suppression of the promoter effect of polyunsaturated fatty acids by the absence of dietary vitamin E in experimental mammary carcinoma. Cancer Letters 114, 233 - 234, 1997. DOI: https://doi.org/10.1016/S0304-3835(97)04671-5
S. Hrelia, A. Bordoni, P. L. Biagi, C. A. Rossi, L. Bernardi, D. F. Horrobin, A. Pession: -Linolenic acid supplementation can affect cancer cell proliferation via modification of fatty acid composition. Biochemical and Biophysical Research Communications 225, 441 - 447, 1996. DOI: https://doi.org/10.1006/bbrc.1996.1192
C. H. Van Aswegen, D. J. du Plessis: Can linoleic acid and gamma-linolenic acid be important in cancer treatment? Medical Hypotheses 43, 415 - 417, 1994. DOI: https://doi.org/10.1016/0306-9877(94)90018-3
W. G. Jiang, S. Hiscox, R. P. Bryce, D. F. Horrobin, R. E. Mansel: The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells. British Journal of Cancer 77, 731 - 738, 1998. DOI: https://doi.org/10.1038/bjc.1998.120
U. N. Das: Abrupt and complete occlusion of tumor-feeding vessels by -linolenic acid. Nutrition 18, 662 - 664, 2002. DOI: https://doi.org/10.1016/S0899-9007(02)00845-6
A. Bakshi, D. Mukherjee, A. Bakshi, A. K. Banerji, U. N. Das: -linolenic acid theraly of human gliomas. Nutrition 19, 305 - 309, 2003. DOI: https://doi.org/10.1016/S0899-9007(02)00862-6
E. Germain, V. Chajes, S. Cognault, C. Lhuillery, P. Bougnoux: Enhancement of doxorobicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. International Journal of Cancer 75, 578 - 583, 1998. DOI: https://doi.org/10.1002/(SICI)1097-0215(19980209)75:4<578::AID-IJC14>3.0.CO;2-5
J. A. Menédez, M. del Mar Barbacid, S. Montero, E. Sevilla, E. Escrich, M. Solanas, H. Cortés-Funes, R. Colomer: Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. European Journal of Cancer 37, 402 - 413, 2001. DOI: https://doi.org/10.1016/S0959-8049(00)00408-1
C. L. Davies, M. Laizidou, A. J. Cooper, I Taylor: Effect of gamma-linolenic acid on cellular uptake of structurally related anthracyclines in human drug sensitive and multidrug resistant bladder and breast cancer cell lines. European Journal of Cancer 35, 1534 - 1540, 1999. DOI: https://doi.org/10.1016/S0959-8049(99)00181-1
M. W. Pariza, Y. Park, M. E. Cook: The biological active isomers of conjugated linoleic acid. Progress in Lipid Research, 40, 283 - 298, 2001. DOI: https://doi.org/10.1016/S0163-7827(01)00008-X
C. Ip, J. A. Scimeca: Conjugated linoleic acid and linoleic acid are distinctive modulators of mammary carcinogenesis. Nutrition and Cancer 27, 131 - 135, 1997. DOI: https://doi.org/10.1080/01635589709514514
M. Ip, P. A. Masso-Welch, S. F. Shoemaker, K. W. Shea, C. Ip: Conjugated linoleic acid inhibits proliferation and induce apoptosis of normal rat mammary epithelial cells in primary culture. Experimental Cell Research 250, 22 - 34, 1999. DOI: https://doi.org/10.1006/excr.1999.4499
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
